26th Nicotine Dependence Conference 2019
Course Directors: J. Taylor Hays, M.D. and Michael V. Burke, Ed.D.
The 26th annual Nicotine Dependence Center conference will explore the continuum of risk of cigarettes, tobacco products, e-cigarettes, and approved pharmacotherapies for treating tobacco use disorder. The conference will work to answer:
- What do we know about the relative health risks of cigarettes, other tobacco products, and vaping devices?
- What is the role and relative effectiveness of e-cigarettes compared with approved medications for addressing tobacco dependence?
- How do e-cigarettes and new tobacco products threaten public health as gateways into nicotine addiction for young people?
Highlights of the conference include:
- Cutting-edge information on FDA approved medications for treating tobacco dependence.
- Updates on current prevalence trends and the regulatory landscape for the treatment of patients.
- Opportunities to network and share professional perspectives on the impact of current changes in the clinical practice.
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact Cathy Schilling.
This program is designed for physicians and other health care professionals experienced in working with tobacco dependent patients, and who are interested in incorporating more effective treatment into their practice and/or developing more comprehensive services to meet the needs of highly tobacco dependent patients. Physicians, tobacco treatment specialists, nurse practitioners, physician assistants, dentists, pharmacists, psychologists, chemical dependency counselors, respiratory therapists, nurses, dental hygienists, wellness coaches, social workers and other allied health professionals may find the conference beneficial in working with this challenging population of patients.
Upon completion of this activity, participants should be able to:
- Identify up-to-date information on prevalence and relative risks of tobacco, e-cigarettes, and FDA approved medications for treating tobacco use disorder.
- Discuss strategies for treating tobacco use disorder within the context of rapidly evolving nicotine delivery products.
- Describe the current regulatory state and plans for regulating nicotine delivery products in USA
Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates the General Session of this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants can earn up to 16 ANCC nursing contact hours commensurate with the extent of their participation in the activity. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
- 16.00 AMA PRA Category 1 Credit™
- 16.00 ANCC
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to firstname.lastname@example.org. When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.